nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—SHBG—hindlimb—muscle cancer	0.0188	0.338	CbGeAlD
Etonogestrel—Bladder pain—Methotrexate—muscle cancer	0.0045	0.00477	CcSEcCtD
Etonogestrel—Bone pain—Doxorubicin—muscle cancer	0.0045	0.00477	CcSEcCtD
Etonogestrel—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00436	0.00462	CcSEcCtD
Etonogestrel—Back pain—Vincristine—muscle cancer	0.00434	0.0046	CcSEcCtD
Etonogestrel—Vaginal inflammation—Doxorubicin—muscle cancer	0.00431	0.00457	CcSEcCtD
Etonogestrel—Hepatocellular injury—Doxorubicin—muscle cancer	0.00431	0.00457	CcSEcCtD
Etonogestrel—Injection site reaction—Doxorubicin—muscle cancer	0.00429	0.00454	CcSEcCtD
Etonogestrel—Myalgia—Dactinomycin—muscle cancer	0.00427	0.00453	CcSEcCtD
Etonogestrel—Discomfort—Dactinomycin—muscle cancer	0.00422	0.00447	CcSEcCtD
Etonogestrel—Cystitis noninfective—Doxorubicin—muscle cancer	0.00421	0.00446	CcSEcCtD
Etonogestrel—Influenza like illness—Doxorubicin—muscle cancer	0.00419	0.00443	CcSEcCtD
Etonogestrel—Cystitis—Doxorubicin—muscle cancer	0.00416	0.00441	CcSEcCtD
Etonogestrel—Hypoaesthesia—Etoposide—muscle cancer	0.00415	0.0044	CcSEcCtD
Etonogestrel—Urinary tract disorder—Etoposide—muscle cancer	0.00412	0.00437	CcSEcCtD
Etonogestrel—Oedema—Dactinomycin—muscle cancer	0.0041	0.00434	CcSEcCtD
Etonogestrel—Fluid retention—Doxorubicin—muscle cancer	0.00409	0.00433	CcSEcCtD
Etonogestrel—Urethral disorder—Etoposide—muscle cancer	0.00409	0.00433	CcSEcCtD
Etonogestrel—Infection—Dactinomycin—muscle cancer	0.00407	0.00431	CcSEcCtD
Etonogestrel—Vaginal infection—Doxorubicin—muscle cancer	0.00407	0.00431	CcSEcCtD
Etonogestrel—Anorexia—Dactinomycin—muscle cancer	0.00391	0.00414	CcSEcCtD
Etonogestrel—Eye disorder—Etoposide—muscle cancer	0.0039	0.00413	CcSEcCtD
Etonogestrel—Bladder pain—Doxorubicin—muscle cancer	0.0039	0.00413	CcSEcCtD
Etonogestrel—Neoplasm—Doxorubicin—muscle cancer	0.0039	0.00413	CcSEcCtD
Etonogestrel—Convulsion—Vincristine—muscle cancer	0.00389	0.00412	CcSEcCtD
Etonogestrel—Hypertension—Vincristine—muscle cancer	0.00387	0.0041	CcSEcCtD
Etonogestrel—Myalgia—Vincristine—muscle cancer	0.00382	0.00404	CcSEcCtD
Etonogestrel—Visual disturbance—Methotrexate—muscle cancer	0.00381	0.00404	CcSEcCtD
Etonogestrel—PGR—smooth muscle tissue—muscle cancer	0.0038	0.0681	CbGeAlD
Etonogestrel—Angiopathy—Etoposide—muscle cancer	0.00379	0.00401	CcSEcCtD
Etonogestrel—ESR1—embryo—muscle cancer	0.00378	0.0678	CbGeAlD
Etonogestrel—Immune system disorder—Etoposide—muscle cancer	0.00377	0.00399	CcSEcCtD
Etonogestrel—Abnormal vision—Doxorubicin—muscle cancer	0.00376	0.00398	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00373	0.00395	CcSEcCtD
Etonogestrel—Alopecia—Etoposide—muscle cancer	0.00369	0.00391	CcSEcCtD
Etonogestrel—Oedema—Vincristine—muscle cancer	0.00366	0.00388	CcSEcCtD
Etonogestrel—Anaphylactic shock—Vincristine—muscle cancer	0.00366	0.00388	CcSEcCtD
Etonogestrel—Infection—Vincristine—muscle cancer	0.00364	0.00385	CcSEcCtD
Etonogestrel—Nervous system disorder—Vincristine—muscle cancer	0.00359	0.0038	CcSEcCtD
Etonogestrel—Decreased appetite—Dactinomycin—muscle cancer	0.00356	0.00377	CcSEcCtD
Etonogestrel—Fatigue—Dactinomycin—muscle cancer	0.00353	0.00374	CcSEcCtD
Etonogestrel—Back pain—Etoposide—muscle cancer	0.00351	0.00372	CcSEcCtD
Etonogestrel—Pain—Dactinomycin—muscle cancer	0.0035	0.00371	CcSEcCtD
Etonogestrel—Muscle spasms—Etoposide—muscle cancer	0.00349	0.0037	CcSEcCtD
Etonogestrel—Anorexia—Vincristine—muscle cancer	0.00349	0.0037	CcSEcCtD
Etonogestrel—Eczema—Doxorubicin—muscle cancer	0.00348	0.00369	CcSEcCtD
Etonogestrel—Irritability—Methotrexate—muscle cancer	0.00345	0.00365	CcSEcCtD
Etonogestrel—Mood swings—Methotrexate—muscle cancer	0.00342	0.00363	CcSEcCtD
Etonogestrel—Feeling abnormal—Dactinomycin—muscle cancer	0.00338	0.00358	CcSEcCtD
Etonogestrel—Ill-defined disorder—Etoposide—muscle cancer	0.00337	0.00357	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00335	0.00355	CcSEcCtD
Etonogestrel—Hot flush—Doxorubicin—muscle cancer	0.00335	0.00354	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00334	0.00353	CcSEcCtD
Etonogestrel—Increased appetite—Doxorubicin—muscle cancer	0.00333	0.00353	CcSEcCtD
Etonogestrel—Menopausal symptoms—Doxorubicin—muscle cancer	0.00332	0.00351	CcSEcCtD
Etonogestrel—Insomnia—Vincristine—muscle cancer	0.00331	0.00351	CcSEcCtD
Etonogestrel—Paraesthesia—Vincristine—muscle cancer	0.00329	0.00348	CcSEcCtD
Etonogestrel—Malaise—Etoposide—muscle cancer	0.00328	0.00347	CcSEcCtD
Etonogestrel—Breast disorder—Methotrexate—muscle cancer	0.00327	0.00346	CcSEcCtD
Etonogestrel—Body temperature increased—Dactinomycin—muscle cancer	0.00324	0.00343	CcSEcCtD
Etonogestrel—Abdominal pain—Dactinomycin—muscle cancer	0.00324	0.00343	CcSEcCtD
Etonogestrel—Decreased appetite—Vincristine—muscle cancer	0.00318	0.00337	CcSEcCtD
Etonogestrel—Cough—Etoposide—muscle cancer	0.00317	0.00336	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Vincristine—muscle cancer	0.00316	0.00335	CcSEcCtD
Etonogestrel—Fatigue—Vincristine—muscle cancer	0.00316	0.00334	CcSEcCtD
Etonogestrel—Convulsion—Etoposide—muscle cancer	0.00315	0.00333	CcSEcCtD
Etonogestrel—Hypertension—Etoposide—muscle cancer	0.00314	0.00332	CcSEcCtD
Etonogestrel—Constipation—Vincristine—muscle cancer	0.00313	0.00332	CcSEcCtD
Etonogestrel—Pain—Vincristine—muscle cancer	0.00313	0.00332	CcSEcCtD
Etonogestrel—Pain in extremity—Doxorubicin—muscle cancer	0.00313	0.00331	CcSEcCtD
Etonogestrel—Asthma—Methotrexate—muscle cancer	0.00312	0.00331	CcSEcCtD
Etonogestrel—Migraine—Doxorubicin—muscle cancer	0.00308	0.00326	CcSEcCtD
Etonogestrel—Affect lability—Doxorubicin—muscle cancer	0.00308	0.00326	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00307	0.00325	CcSEcCtD
Etonogestrel—SHBG—bone marrow—muscle cancer	0.00307	0.055	CbGeAlD
Etonogestrel—Discomfort—Etoposide—muscle cancer	0.00306	0.00324	CcSEcCtD
Etonogestrel—Hypersensitivity—Dactinomycin—muscle cancer	0.00302	0.0032	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Vincristine—muscle cancer	0.00299	0.00317	CcSEcCtD
Etonogestrel—ESR1—smooth muscle tissue—muscle cancer	0.00297	0.0533	CbGeAlD
Etonogestrel—Anaphylactic shock—Etoposide—muscle cancer	0.00297	0.00314	CcSEcCtD
Etonogestrel—Mood swings—Doxorubicin—muscle cancer	0.00296	0.00314	CcSEcCtD
Etonogestrel—Infection—Etoposide—muscle cancer	0.00295	0.00312	CcSEcCtD
Etonogestrel—Asthenia—Dactinomycin—muscle cancer	0.00294	0.00311	CcSEcCtD
Etonogestrel—SHBG—vagina—muscle cancer	0.00294	0.0527	CbGeAlD
Etonogestrel—Dysuria—Methotrexate—muscle cancer	0.00292	0.00309	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Methotrexate—muscle cancer	0.0029	0.00307	CcSEcCtD
Etonogestrel—Body temperature increased—Vincristine—muscle cancer	0.00289	0.00306	CcSEcCtD
Etonogestrel—Abdominal pain—Vincristine—muscle cancer	0.00289	0.00306	CcSEcCtD
Etonogestrel—Skin disorder—Etoposide—muscle cancer	0.00288	0.00305	CcSEcCtD
Etonogestrel—ESR1—renal system—muscle cancer	0.00286	0.0513	CbGeAlD
Etonogestrel—Breast disorder—Doxorubicin—muscle cancer	0.00283	0.003	CcSEcCtD
Etonogestrel—Anorexia—Etoposide—muscle cancer	0.00283	0.00299	CcSEcCtD
Etonogestrel—Diarrhoea—Dactinomycin—muscle cancer	0.0028	0.00297	CcSEcCtD
Etonogestrel—Infestation NOS—Methotrexate—muscle cancer	0.00279	0.00295	CcSEcCtD
Etonogestrel—Infestation—Methotrexate—muscle cancer	0.00279	0.00295	CcSEcCtD
Etonogestrel—Depression—Methotrexate—muscle cancer	0.00278	0.00294	CcSEcCtD
Etonogestrel—Gastritis—Doxorubicin—muscle cancer	0.00277	0.00293	CcSEcCtD
Etonogestrel—Abdominal distension—Doxorubicin—muscle cancer	0.00272	0.00288	CcSEcCtD
Etonogestrel—Asthma—Doxorubicin—muscle cancer	0.0027	0.00286	CcSEcCtD
Etonogestrel—Hypersensitivity—Vincristine—muscle cancer	0.0027	0.00286	CcSEcCtD
Etonogestrel—Paraesthesia—Etoposide—muscle cancer	0.00266	0.00282	CcSEcCtD
Etonogestrel—PGR—vagina—muscle cancer	0.00265	0.0475	CbGeAlD
Etonogestrel—Somnolence—Etoposide—muscle cancer	0.00264	0.00279	CcSEcCtD
Etonogestrel—Asthenia—Vincristine—muscle cancer	0.00263	0.00278	CcSEcCtD
Etonogestrel—SHBG—testis—muscle cancer	0.00262	0.0471	CbGeAlD
Etonogestrel—Vomiting—Dactinomycin—muscle cancer	0.00261	0.00276	CcSEcCtD
Etonogestrel—Bronchitis—Doxorubicin—muscle cancer	0.0026	0.00275	CcSEcCtD
Etonogestrel—Rash—Dactinomycin—muscle cancer	0.00258	0.00274	CcSEcCtD
Etonogestrel—Decreased appetite—Etoposide—muscle cancer	0.00258	0.00273	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Etoposide—muscle cancer	0.00256	0.00271	CcSEcCtD
Etonogestrel—Fatigue—Etoposide—muscle cancer	0.00256	0.00271	CcSEcCtD
Etonogestrel—Pain—Etoposide—muscle cancer	0.00254	0.00269	CcSEcCtD
Etonogestrel—Constipation—Etoposide—muscle cancer	0.00254	0.00269	CcSEcCtD
Etonogestrel—Dysuria—Doxorubicin—muscle cancer	0.00253	0.00268	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00251	0.00266	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—muscle cancer	0.00251	0.00266	CcSEcCtD
Etonogestrel—Diarrhoea—Vincristine—muscle cancer	0.0025	0.00265	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—muscle cancer	0.0025	0.00265	CcSEcCtD
Etonogestrel—Pollakiuria—Doxorubicin—muscle cancer	0.0025	0.00265	CcSEcCtD
Etonogestrel—Pharyngitis—Methotrexate—muscle cancer	0.00248	0.00263	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—muscle cancer	0.00247	0.00262	CcSEcCtD
Etonogestrel—Weight increased—Doxorubicin—muscle cancer	0.00246	0.00261	CcSEcCtD
Etonogestrel—Urethral disorder—Methotrexate—muscle cancer	0.00245	0.0026	CcSEcCtD
Etonogestrel—Weight decreased—Doxorubicin—muscle cancer	0.00245	0.00259	CcSEcCtD
Etonogestrel—PGR—head—muscle cancer	0.00245	0.0439	CbGeAlD
Etonogestrel—Feeling abnormal—Etoposide—muscle cancer	0.00244	0.00259	CcSEcCtD
Etonogestrel—Nausea—Dactinomycin—muscle cancer	0.00243	0.00258	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Etoposide—muscle cancer	0.00243	0.00257	CcSEcCtD
Etonogestrel—Dizziness—Vincristine—muscle cancer	0.00242	0.00256	CcSEcCtD
Etonogestrel—Infestation—Doxorubicin—muscle cancer	0.00241	0.00255	CcSEcCtD
Etonogestrel—Infestation NOS—Doxorubicin—muscle cancer	0.00241	0.00255	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—muscle cancer	0.00241	0.00255	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00236	0.0025	CcSEcCtD
Etonogestrel—PGR—testis—muscle cancer	0.00236	0.0424	CbGeAlD
Etonogestrel—Urticaria—Etoposide—muscle cancer	0.00236	0.0025	CcSEcCtD
Etonogestrel—Body temperature increased—Etoposide—muscle cancer	0.00234	0.00248	CcSEcCtD
Etonogestrel—Abdominal pain—Etoposide—muscle cancer	0.00234	0.00248	CcSEcCtD
Etonogestrel—Urinary tract infection—Doxorubicin—muscle cancer	0.00234	0.00248	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—muscle cancer	0.00234	0.00247	CcSEcCtD
Etonogestrel—Vomiting—Vincristine—muscle cancer	0.00233	0.00247	CcSEcCtD
Etonogestrel—Rash—Vincristine—muscle cancer	0.00231	0.00244	CcSEcCtD
Etonogestrel—Dermatitis—Vincristine—muscle cancer	0.00231	0.00244	CcSEcCtD
Etonogestrel—Headache—Vincristine—muscle cancer	0.00229	0.00243	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—muscle cancer	0.00227	0.0024	CcSEcCtD
Etonogestrel—Sinusitis—Doxorubicin—muscle cancer	0.00226	0.0024	CcSEcCtD
Etonogestrel—Immune system disorder—Methotrexate—muscle cancer	0.00226	0.00239	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—muscle cancer	0.00221	0.00234	CcSEcCtD
Etonogestrel—Mental disorder—Methotrexate—muscle cancer	0.00219	0.00232	CcSEcCtD
Etonogestrel—Hypersensitivity—Etoposide—muscle cancer	0.00218	0.00231	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—muscle cancer	0.00218	0.00231	CcSEcCtD
Etonogestrel—Malnutrition—Methotrexate—muscle cancer	0.00218	0.00231	CcSEcCtD
Etonogestrel—Haemoglobin—Doxorubicin—muscle cancer	0.00218	0.0023	CcSEcCtD
Etonogestrel—Nausea—Vincristine—muscle cancer	0.00217	0.0023	CcSEcCtD
Etonogestrel—Rhinitis—Doxorubicin—muscle cancer	0.00217	0.0023	CcSEcCtD
Etonogestrel—Haemorrhage—Doxorubicin—muscle cancer	0.00217	0.00229	CcSEcCtD
Etonogestrel—Hypoaesthesia—Doxorubicin—muscle cancer	0.00215	0.00228	CcSEcCtD
Etonogestrel—Pharyngitis—Doxorubicin—muscle cancer	0.00215	0.00228	CcSEcCtD
Etonogestrel—Urinary tract disorder—Doxorubicin—muscle cancer	0.00214	0.00226	CcSEcCtD
Etonogestrel—Asthenia—Etoposide—muscle cancer	0.00213	0.00225	CcSEcCtD
Etonogestrel—Connective tissue disorder—Doxorubicin—muscle cancer	0.00213	0.00225	CcSEcCtD
Etonogestrel—Urethral disorder—Doxorubicin—muscle cancer	0.00212	0.00225	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—muscle cancer	0.00211	0.00223	CcSEcCtD
Etonogestrel—Pruritus—Etoposide—muscle cancer	0.0021	0.00222	CcSEcCtD
Etonogestrel—Visual impairment—Doxorubicin—muscle cancer	0.00209	0.00221	CcSEcCtD
Etonogestrel—ESR1—vagina—muscle cancer	0.00207	0.0372	CbGeAlD
Etonogestrel—Diarrhoea—Etoposide—muscle cancer	0.00203	0.00215	CcSEcCtD
Etonogestrel—Eye disorder—Doxorubicin—muscle cancer	0.00202	0.00214	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—muscle cancer	0.00202	0.00214	CcSEcCtD
Etonogestrel—Angiopathy—Doxorubicin—muscle cancer	0.00196	0.00208	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—muscle cancer	0.00196	0.00208	CcSEcCtD
Etonogestrel—Dizziness—Etoposide—muscle cancer	0.00196	0.00208	CcSEcCtD
Etonogestrel—Immune system disorder—Doxorubicin—muscle cancer	0.00196	0.00207	CcSEcCtD
Etonogestrel—ESR1—head—muscle cancer	0.00191	0.0343	CbGeAlD
Etonogestrel—Alopecia—Doxorubicin—muscle cancer	0.00191	0.00203	CcSEcCtD
Etonogestrel—Cough—Methotrexate—muscle cancer	0.0019	0.00201	CcSEcCtD
Etonogestrel—Mental disorder—Doxorubicin—muscle cancer	0.0019	0.00201	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—muscle cancer	0.00189	0.002	CcSEcCtD
Etonogestrel—Vomiting—Etoposide—muscle cancer	0.00189	0.002	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—muscle cancer	0.00188	0.002	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—muscle cancer	0.00188	0.002	CcSEcCtD
Etonogestrel—Rash—Etoposide—muscle cancer	0.00187	0.00198	CcSEcCtD
Etonogestrel—Dermatitis—Etoposide—muscle cancer	0.00187	0.00198	CcSEcCtD
Etonogestrel—Headache—Etoposide—muscle cancer	0.00186	0.00197	CcSEcCtD
Etonogestrel—Flatulence—Doxorubicin—muscle cancer	0.00186	0.00197	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—muscle cancer	0.00185	0.00196	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—muscle cancer	0.00185	0.00196	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—muscle cancer	0.00185	0.00196	CcSEcCtD
Etonogestrel—ESR1—testis—muscle cancer	0.00185	0.0332	CbGeAlD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00184	0.00195	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—muscle cancer	0.00183	0.00194	CcSEcCtD
Etonogestrel—Nervousness—Doxorubicin—muscle cancer	0.00183	0.00194	CcSEcCtD
Etonogestrel—Back pain—Doxorubicin—muscle cancer	0.00182	0.00193	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—muscle cancer	0.00181	0.00192	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methotrexate—muscle cancer	0.00178	0.00188	CcSEcCtD
Etonogestrel—Infection—Methotrexate—muscle cancer	0.00176	0.00187	CcSEcCtD
Etonogestrel—Nausea—Etoposide—muscle cancer	0.00176	0.00187	CcSEcCtD
Etonogestrel—Ill-defined disorder—Doxorubicin—muscle cancer	0.00175	0.00185	CcSEcCtD
Etonogestrel—Nervous system disorder—Methotrexate—muscle cancer	0.00174	0.00184	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—muscle cancer	0.00173	0.00183	CcSEcCtD
Etonogestrel—Malaise—Doxorubicin—muscle cancer	0.0017	0.0018	CcSEcCtD
Etonogestrel—Anorexia—Methotrexate—muscle cancer	0.00169	0.00179	CcSEcCtD
Etonogestrel—Cough—Doxorubicin—muscle cancer	0.00164	0.00174	CcSEcCtD
Etonogestrel—Convulsion—Doxorubicin—muscle cancer	0.00163	0.00173	CcSEcCtD
Etonogestrel—Hypertension—Doxorubicin—muscle cancer	0.00163	0.00172	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00162	0.00171	CcSEcCtD
Etonogestrel—Insomnia—Methotrexate—muscle cancer	0.00161	0.0017	CcSEcCtD
Etonogestrel—Arthralgia—Doxorubicin—muscle cancer	0.0016	0.0017	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—muscle cancer	0.0016	0.0017	CcSEcCtD
Etonogestrel—Anxiety—Doxorubicin—muscle cancer	0.0016	0.00169	CcSEcCtD
Etonogestrel—CYP3A4—renal system—muscle cancer	0.0016	0.0286	CbGeAlD
Etonogestrel—Paraesthesia—Methotrexate—muscle cancer	0.0016	0.00169	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00159	0.00169	CcSEcCtD
Etonogestrel—Discomfort—Doxorubicin—muscle cancer	0.00159	0.00168	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—muscle cancer	0.00158	0.00167	CcSEcCtD
Etonogestrel—Dyspepsia—Methotrexate—muscle cancer	0.00156	0.00166	CcSEcCtD
Etonogestrel—Decreased appetite—Methotrexate—muscle cancer	0.00154	0.00164	CcSEcCtD
Etonogestrel—Anaphylactic shock—Doxorubicin—muscle cancer	0.00154	0.00163	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—muscle cancer	0.00154	0.00163	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00153	0.00162	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—muscle cancer	0.00153	0.00162	CcSEcCtD
Etonogestrel—Infection—Doxorubicin—muscle cancer	0.00153	0.00162	CcSEcCtD
Etonogestrel—Pain—Methotrexate—muscle cancer	0.00152	0.00161	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—muscle cancer	0.00151	0.0016	CcSEcCtD
Etonogestrel—Skin disorder—Doxorubicin—muscle cancer	0.00149	0.00158	CcSEcCtD
Etonogestrel—Anorexia—Doxorubicin—muscle cancer	0.00147	0.00155	CcSEcCtD
Etonogestrel—Feeling abnormal—Methotrexate—muscle cancer	0.00146	0.00155	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methotrexate—muscle cancer	0.00145	0.00154	CcSEcCtD
Etonogestrel—Urticaria—Methotrexate—muscle cancer	0.00141	0.00149	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—muscle cancer	0.0014	0.00149	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—muscle cancer	0.0014	0.00149	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.0014	0.00148	CcSEcCtD
Etonogestrel—Insomnia—Doxorubicin—muscle cancer	0.00139	0.00147	CcSEcCtD
Etonogestrel—Paraesthesia—Doxorubicin—muscle cancer	0.00138	0.00146	CcSEcCtD
Etonogestrel—Somnolence—Doxorubicin—muscle cancer	0.00137	0.00145	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—muscle cancer	0.00135	0.00143	CcSEcCtD
Etonogestrel—Decreased appetite—Doxorubicin—muscle cancer	0.00134	0.00142	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00133	0.00141	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—muscle cancer	0.00133	0.0014	CcSEcCtD
Etonogestrel—Pain—Doxorubicin—muscle cancer	0.00132	0.00139	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—muscle cancer	0.00132	0.00139	CcSEcCtD
Etonogestrel—Hypersensitivity—Methotrexate—muscle cancer	0.00131	0.00139	CcSEcCtD
Etonogestrel—Asthenia—Methotrexate—muscle cancer	0.00127	0.00135	CcSEcCtD
Etonogestrel—Feeling abnormal—Doxorubicin—muscle cancer	0.00127	0.00134	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00126	0.00133	CcSEcCtD
Etonogestrel—Pruritus—Methotrexate—muscle cancer	0.00126	0.00133	CcSEcCtD
Etonogestrel—Urticaria—Doxorubicin—muscle cancer	0.00122	0.00129	CcSEcCtD
Etonogestrel—Abdominal pain—Doxorubicin—muscle cancer	0.00122	0.00129	CcSEcCtD
Etonogestrel—Body temperature increased—Doxorubicin—muscle cancer	0.00122	0.00129	CcSEcCtD
Etonogestrel—Diarrhoea—Methotrexate—muscle cancer	0.00122	0.00129	CcSEcCtD
Etonogestrel—Dizziness—Methotrexate—muscle cancer	0.00117	0.00124	CcSEcCtD
Etonogestrel—Hypersensitivity—Doxorubicin—muscle cancer	0.00113	0.0012	CcSEcCtD
Etonogestrel—Vomiting—Methotrexate—muscle cancer	0.00113	0.0012	CcSEcCtD
Etonogestrel—Rash—Methotrexate—muscle cancer	0.00112	0.00119	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—muscle cancer	0.00112	0.00119	CcSEcCtD
Etonogestrel—Headache—Methotrexate—muscle cancer	0.00111	0.00118	CcSEcCtD
Etonogestrel—Asthenia—Doxorubicin—muscle cancer	0.0011	0.00117	CcSEcCtD
Etonogestrel—Pruritus—Doxorubicin—muscle cancer	0.00109	0.00115	CcSEcCtD
Etonogestrel—Nausea—Methotrexate—muscle cancer	0.00106	0.00112	CcSEcCtD
Etonogestrel—Diarrhoea—Doxorubicin—muscle cancer	0.00105	0.00111	CcSEcCtD
Etonogestrel—Dizziness—Doxorubicin—muscle cancer	0.00102	0.00108	CcSEcCtD
Etonogestrel—Vomiting—Doxorubicin—muscle cancer	0.000978	0.00104	CcSEcCtD
Etonogestrel—Rash—Doxorubicin—muscle cancer	0.00097	0.00103	CcSEcCtD
Etonogestrel—Dermatitis—Doxorubicin—muscle cancer	0.000969	0.00103	CcSEcCtD
Etonogestrel—Headache—Doxorubicin—muscle cancer	0.000964	0.00102	CcSEcCtD
Etonogestrel—Nausea—Doxorubicin—muscle cancer	0.000914	0.000968	CcSEcCtD
